Trial · NCT07891936
Registered outcomes67
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 67
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Muscle Quality | From enrollment to the end of treatment at 32 weeks | It is defined as the capacity of skeletal muscle to generate strength relative to its mass, integrating both structural and functional aspects. It will be expressed as the ratio between the estimated 1-RM strength and muscle mass measured by dual-energy X-ray absorptiometry (DEXA) |
| Secondary | Nutritional profile | From enrollment to the end of treatment at 32 weeks | This will be assessed through a nutritional interview conducted by a professional, which will include a complete dietary history, a 24-hour dietary recall (24hR), and a food frequency questionnaire (FFQ) |
| Secondary | Body composition | From enrollment to the end of treatment at 32 weeks | assessed through basic anthropometry: weight in kilogram (kg) |
| Secondary | Body composition | From enrollment to the end of treatment at 32 weeks | assessed through basic anthropometry: height in centimeter (cm) |
| Secondary | Body composition | From enrollment to the end of treatment at 32 weeks | assessed through basic anthropometry: body mass index (BMI), weight and height will be combined to report BMI in kg/m\^2 |
| Secondary | Body composition | From enrollment to the end of treatment at 32 weeks | Dual X-Ray Densitometry: body adiposity index, (BAI) in perctange (%) |
| Secondary | Body composition | From enrollment to the end of treatment at 32 weeks | Dual X-Ray Densitometry: fat mass index (FMI) kilograms per square meter. kg/m² |
| Secondary | Body composition | From enrollment to the end of treatment at 32 weeks | Dual X-Ray Densitometry: visceral adipose tissue area, VAT Area in square centimeter (cm²) |
| Secondary | Body composition | From enrollment to the end of treatment at 32 weeks | Dual X-Ray Densitometry: skeletal muscle mass index, (SMI) kilograms per square meter. kg/m² |
| Secondary | Body composition | From enrollment to the end of treatment at 32 weeks | Dual X-Ray Densitometry: appendicular skeletal muscle mass index, (ASM). kilograms per square meter. kg/m² |
| Secondary | Physical fitness | From enrollment to the end of treatment at 32 weeks | Cardiorespiratory fitness assessed via a performance test with gas analysis using ergometry (incremental test to exhaustion): VO2 max (L/min) in First Ventilatory Threshold, Second Ventilatory Threshold and at maximum test time. |
| Secondary | Physical fitness | From enrollment to the end of treatment at 32 weeks | Cardiorespiratory fitness assessed via a performance test with gas analysis using ergometry (incremental test to exhaustion): Relative VO2 (ml/kg/min) in First Ventilatory Threshold, Second Ventilatory Threshold and at maximum test time. |
| Secondary | Physical fitness | From enrollment to the end of treatment at 32 weeks | Cardiorespiratory fitness assessed via a performance test with gas analysis using ergometry (incremental test to exhaustion): Absolute VO2 (L/min) in First Ventilatory Threshold, Second Ventilatory Threshold and at maximum test time. |
| Secondary | Physical fitness | From enrollment to the end of treatment at 32 weeks | Cardiorespiratory fitness assessed via a performance test with gas analysis using ergometry (incremental test to exhaustion): Absolute VCO2 (L/min) in First Ventilatory Threshold, Second Ventilatory Threshold and at maximum test time. |
| Secondary | Physical fitness | From enrollment to the end of treatment at 32 weeks | Cardiorespiratory fitness assessed via a performance test with gas analysis using ergometry (incremental test to exhaustion): Respiratory exchange ratio, RER in First Ventilatory Threshold, Second Ventilatory Threshold and at maximum test time. |
| Secondary | Physical fitness | From enrollment to the end of treatment at 32 weeks | Cardiorespiratory fitness assessed via a performance test with gas analysis using ergometry (incremental test to exhaustion): Ventilatory equivalent, rate of ventilation and absolute O2 (VE/O2) in First Ventilatory Threshold, Second Ventilatory Threshold and at maximum test time. |
| Secondary | Physical fitness | From enrollment to the end of treatment at 32 weeks | Cardiorespiratory fitness assessed via a performance test with gas analysis using ergometry (incremental test to exhaustion): Ventilatory equivalent, rate of ventilation and absolute CO2 (VE/CO2) in First Ventilatory Threshold, Second Ventilatory Threshold and at maximum test time. |
| Secondary | Physical fitness | From enrollment to the end of treatment at 32 weeks | (1) Cardiorespiratory fitness assessed via a performance test with gas analysis using ergometry (incremental test to exhaustion): Speed (km/h) in First Ventilatory Threshold, Second Ventilatory Threshold and at maximum test time. |
| Secondary | Physical fitness | From enrollment to the end of treatment at 32 weeks | (1) Cardiorespiratory fitness assessed via a performance test with gas analysis using ergometry (incremental test to exhaustion): time in sencond (s) when it appears First Ventilatory Threshold, Second Ventilatory Threshold and at maximum test time. |
| Secondary | Physical fitness | From enrollment to the end of treatment at 32 weeks | (1) Cardiorespiratory fitness assessed via a performance test with gas analysis using ergometry (incremental test to exhaustion): V-Slope break-point (%) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07891936/registered